Translating pharmacogenomic sequencing data into drug response predictions—How to interpret variants of unknown significance

Abstract excerpt

The rapid development of sequencing technologies during the past 20 years has provided a variety of methods and tools to interrogate human genomic variations at the population level. Pharmacogenes are well known to be highly polymorphic and a plethora of pharmacogenomic variants has been identified in population sequencing data. However, so far only a small number of these variants have been functionally...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Berberine and alkaloids research
• Share to Genomics and Rare Diseases
• Share to Pharmacogenetics and Drug Metabolism